Intrinsiqq
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. Financials

EDSA

Compare

All currency values in $ millions unless otherwise noted

Scroll

Income Statement
TTM
SEP 2025
SEP 2024
SEP 2023
SEP 2022
SEP 2021
Revenues
Revenue$0$0$0$0$0$0
Cost of Revenue–––––$0
Gross Profit–––––$0
Total Operating Expenses–––––$13
Operating Income-$14-$7-$6-$9-$18-$13
Income Tax Expense–$0$0$0$0$0
Net Income
Net Income-$14-$7-$6-$8-$18-$13
Per Share Data
Revenue Per Share$0.00$0.00$0.00$0.00$0.00$0.00
EPS (Basic)-$1.69-$1.27-$1.93-$0.42-$7.35-$7.70
EPS (Diluted)-$1.69-$1.27-$1.93-$0.42-$7.35-$7.70
Shares Outstanding9.0M5.7M3.2M20.0M2.4M1.7M

Edesa Biotech (EDSA) financials: revenue, profit and margins

Edesa Biotech (EDSA) generated about $0.00 in revenue and -$14 million in net income over the trailing twelve months. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is Edesa Biotech's (EDSA) revenue?+

Edesa Biotech generated about $0.00 in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Edesa Biotech profitable?+

Edesa Biotech reported about -$14 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

Peers

Biotechnology · Pick stocks to compare with EDSA

CompareIntrinsic value
NEWBRY.XSTONewbury Pharmaceuticals AB
€0.11+0.91%40
HPHA.XETRHeidelberg Pharma AG
€2.01-2.90%10
MEDCL.XPARMedincell SA
€26.70-2.05%40
ZTEKZentek Ltd.
€0.33-0.60%40
XTXXFAdastra Holdings Ltd.
€0.08+0.00%40
XRTXXORTX Therapeutics Inc.
$0.84-5.73%10
VALNValneva SE Sponsored ADR
$5.16-3.82%0
TRIBTrinity Biotech plc Sponsored ADR
$6.24+13.66%10

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing EDSA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.